These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30793767)

  • 1. Tumor-derived exosomes: Implication in angiogenesis and antiangiogenesis cancer therapy.
    Aslan C; Maralbashi S; Salari F; Kahroba H; Sigaroodi F; Kazemi T; Kharaziha P
    J Cell Physiol; 2019 Aug; 234(10):16885-16903. PubMed ID: 30793767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers.
    Olejarz W; Kubiak-Tomaszewska G; Chrzanowska A; Lorenc T
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications.
    Ahmadi M; Rezaie J
    J Transl Med; 2020 Jun; 18(1):249. PubMed ID: 32571337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Extracellular Vesicles in Hematological Malignancies.
    Raimondo S; Corrado C; Raimondi L; De Leo G; Alessandro R
    Biomed Res Int; 2015; 2015():821613. PubMed ID: 26583135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
    Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
    Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
    Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why angiogenesis inhibition? Commentary.
    Boehm-Viswanathan T
    Int J Mol Med; 1999 Oct; 4(4):413-7. PubMed ID: 10493984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hypoxia-induced exosomes in tumor biology.
    Shao C; Yang F; Miao S; Liu W; Wang C; Shu Y; Shen H
    Mol Cancer; 2018 Aug; 17(1):120. PubMed ID: 30098600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary exosomes as potential biomarkers in cancer.
    Nair S; Tang KD; Kenny L; Punyadeera C
    Oral Oncol; 2018 Sep; 84():31-40. PubMed ID: 30115473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies.
    Grothey A; Ellis LM
    Cancer J; 2008; 14(3):170-7. PubMed ID: 18536556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis inhibitors.
    Kiselev SM; Lutsenko SV; Severin SE; Severin ES
    Biochemistry (Mosc); 2003 May; 68(5):497-513. PubMed ID: 12882631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenesis: new frontiers in therapeutic development.
    LaMontagne KR
    Angiogenesis; 2005; 8(4):285-7. PubMed ID: 16400519
    [No Abstract]   [Full Text] [Related]  

  • 14. Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy.
    Fatima F; Nawaz M
    Chin J Cancer; 2015 Sep; 34(12):541-53. PubMed ID: 26369565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenesis therapy. Current and future agents.
    Kieran MW; Billett A
    Hematol Oncol Clin North Am; 2001 Oct; 15(5):835-51, viii. PubMed ID: 11765376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.
    Wang Y; Wang L; Chen C; Chu X
    Mol Cancer; 2018 Feb; 17(1):22. PubMed ID: 29415727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenesis therapeutic strategies in prostate cancer.
    Macpherson GR; Ng SS; Lakhani NJ; Price DK; Venitz J; Figg WD
    Cancer Metastasis Rev; 2002; 21(1):93-106. PubMed ID: 12400998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.
    Gagne P; Akalu A; Brooks PC
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor vasculature: the Achilles' heel of cancer?
    Johannessen TC; Wagner M; Straume O; Bjerkvig R; Eikesdal HP
    Expert Opin Ther Targets; 2013 Jan; 17(1):7-20. PubMed ID: 23121690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiogenic inhibitors and radiotherapy: from the concept to the clinical trial].
    Cohen-Jonathan Moyal E
    Cancer Radiother; 2009 Oct; 13(6-7):562-7. PubMed ID: 19695923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.